Fig. 5From: An integrated approach of bioinformatic prediction and in vitro analysis identified that miR-34a targets MET and AXL in triple-negative breast cancera MiR-34a expression before induction in SK-BR-3 and MDA-MB-231 cell lines (GSE21719). b AXL gene expression before miR-34a induction in SKBR3 and MDA-MB-231 cell lines (GSE40057)Back to article page